Joint Corp. price target raised to $20 from $15 at Lake Street

Lake Street analyst Ryan Meyers raised the firm’s price target on Joint Corp. to $20 from $15 and keeps a Buy rating on the shares. In the near term, the firm thinks shares may remain range-bound as the company continues to progress through its corporate clinic transition and investors get a better understanding of the new model, but over the long term it thinks the strategy makes sense and believes the company will be able to create shareholder value.